Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
Cathrine Axfors, Perrine Janiaud, Andreas M. Schmitt, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis
Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1541-1541
Open Access | Times Cited: 141
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients
Benoît Misset, Michaël Piagnerelli, Eric A. J. Hoste, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 17, pp. 1590-1600
Open Access | Times Cited: 48
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 8
The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis
Caterina Caminiti, Giuseppe Maglietta, Francesca Diodati, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5470-5470
Open Access | Times Cited: 31
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
Charalampos Filippatos, Ioannis Ntanasis‐Stathopoulos, Kalliopi Sekeri, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 765-765
Open Access | Times Cited: 16
Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial
Visa Nurmi, Richard Mayne, Chanice Knight, et al.
Journal of Infection (2025), pp. 106412-106412
Closed Access
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
Yasser Mohamed, Yousra A. El‐Maradny, Ahmed K. Saleh, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113499-113499
Open Access | Times Cited: 22
Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases
Carlos Martínez-Chinchilla, Lucía Vázquez-Montero, Natalia Palazón‐Carrión, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study
Manuel Rojas, Yhojan Rodríguez, Juan C. Hernández, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial
Leon Peto, Peter Horby, Martin Landray
Advances in Biological Regulation (2022) Vol. 86, pp. 100901-100901
Open Access | Times Cited: 15
Therapeutic role of immunomodulators during the COVID-19 pandemic– a narrative review
Hebah Alhajeri, Fatemah Baroun, Fatemah Abutiban, et al.
Postgraduate Medicine (2022) Vol. 134, Iss. 2, pp. 160-179
Open Access | Times Cited: 14
An interpreter ranking index-based MCDM technique for COVID-19 treatments under a bipolar fuzzy environment
Totan Garai, Harish Garg
Results in Control and Optimization (2023) Vol. 12, pp. 100242-100242
Open Access | Times Cited: 8
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients
Massimo Franchini, Daniele Focosi, Elena Percivalle, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1443-1443
Open Access | Times Cited: 11
Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial
Paola Manzini, Giovannino Ciccone, Francesco Giuseppe De Rosa, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Convalescent Plasma Therapy, Therapeutic Formulations of Repurposed Drugs in 20th Century Epidemics against COVID-19: A Systematic Review
Diego Fernández-Lázaro, Carlos Domínguez Ortega, Nerea Sánchez-Serrano, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1020-1020
Open Access | Times Cited: 10
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management
Marcos I. Restrepo, Judith Marín‐Corral, Juan José Berenguer Rodríguez, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 021-034
Closed Access | Times Cited: 5
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays
Maurice Steenhuis, Elise Wouters, Hubert Schrezenmeier, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 8, pp. 666-673
Closed Access | Times Cited: 5
Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial
Preston Tse, Jiajun Yan, Yang Liu, et al.
Transfusion (2024) Vol. 64, Iss. 4, pp. 606-614
Open Access | Times Cited: 1
The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials
Zhenbei Qian, Zhijin Zhang, Haomiao Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors
Visa Nurmi, Chanice Knight, Lise J Estcourt, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 3, pp. 245-250
Open Access | Times Cited: 4
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry
Peter L. Turecek, Deborah Hibbett, Thomas R. Kreil
Vox Sanguinis (2022) Vol. 117, Iss. 6, pp. 780-788
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top